The Centers for Medicare and Medicaid Services (CMS) identified 15 drugs it has selected for price negotiations with drug ...

Insurer-pharmacy benefit manager (PBM) firms control most of the Medicare Part D market, steering patients to their ...

The drugs treat prostate, breast and blood cancers. About 80,000 people with Medicare Part D coverage used them in a one-year ...

To locate a mental health care professional in your area that accepts Medicare, go to Medicare.gov/care-compare, click on “doctors & clinicians” and type in your location, followed by “clinical ...

Medicare Part A and Part B, also known as “original Medicare,” are standard coverage, but what about Part D, the prescription ...

Semaglutide sells for $997 a month when branded under Ozempic and $1,349 a month for Wegovy. The haircut to Ozempic may have a spillover effect on competitor drugs from Eli Lilly — Mounjaro and ...

Medicare released its next target list of 15 drugs to negotiate prices of, including Novo Nordisk's blockbuster GLP-1 drugs.

The Centers for Medicare and Medicaid Services (CMS) has selected 15 more drugs for Medicare price negotiation, announcing ...

The Congressional Budget Office (CBO) released its latest projections for the budget and economic outlook today, projecting ...

Ozempic and Wegovy, the blockbuster but costly GLP-1 drugs often used for weight loss, are among the 15 medications that will ...

Hays and her husband who have a Medicare Part D drug plan. As a result, she expects to shell out a lot less at the pharmacy ...

The Medicare Payment Advisory Commission today voted to recommend that Congress update Medicare payment rates for hospital ...